GlaxoSmithKline, AmfAR Form Pact to Optimize HIV Treatment in Asia
June 21, 2010
GlaxoSmithKline and amfAR on Thursday announced a project to improve the quality and accessibility of health care for HIV-positive infants and children in Asia. The partners created the two-year, $2 million initiative to produce clinical evidence and develop strategies to support pediatric care, as well as to inform global treatment guidelines.
Wall Street Journal
06.17.2010; Ian Walker, Dow Jones Newswires
This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)